237 related articles for article (PubMed ID: 34019805)
21. Perspective on Precision Medicine in Oncology.
Johnson TM
Pharmacotherapy; 2017 Sep; 37(9):988-989. PubMed ID: 28632968
[TBL] [Abstract][Full Text] [Related]
22. The opportunities and challenges of implementing genomics-informed personalized medicine.
Chisholm RL
Clin Pharmacol Ther; 2013 Aug; 94(2):181-2. PubMed ID: 23872829
[No Abstract] [Full Text] [Related]
23. Precision oncology: East meets West.
Subbiah V; Rodon J; Yap TA
Int J Cancer; 2018 May; 142(9):1734-1737. PubMed ID: 29243227
[No Abstract] [Full Text] [Related]
24. Enabling Precision Oncology Through Precision Diagnostics.
Brown NA; Elenitoba-Johnson KSJ
Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
[TBL] [Abstract][Full Text] [Related]
25. Precision Medicine in Oncology II: Economics of Targeted Agents and Immuno-Oncology Drugs.
Huntington SF; Davidoff AJ; Gross CP
J Clin Oncol; 2020 Feb; 38(4):351-358. PubMed ID: 31804866
[No Abstract] [Full Text] [Related]
26. National Cancer Institute Basket/Umbrella Clinical Trials: MATCH, LungMAP, and Beyond.
Chen AP; Eljanne M; Harris L; Malik S; Seibel NL
Cancer J; 2019; 25(4):272-281. PubMed ID: 31335391
[TBL] [Abstract][Full Text] [Related]
27. Twenty-First Century Precision Medicine in Oncology: Genomic Profiling in Patients With Cancer.
Borad MJ; LoRusso PM
Mayo Clin Proc; 2017 Oct; 92(10):1583-1591. PubMed ID: 28982488
[TBL] [Abstract][Full Text] [Related]
28. Disparities According to Genetic Ancestry in the Use of Precision Oncology Assays.
Mata DA; Rotenstein LS; Ramos MA; Jena AB
N Engl J Med; 2023 Jan; 388(3):281-283. PubMed ID: 36652362
[No Abstract] [Full Text] [Related]
29. Clinical implementation of pharmacogenetics.
García-González X; Cabaleiro T; Herrero MJ; McLeod H; López-Fernández LA
Drug Metab Pers Ther; 2016 Mar; 31(1):9-16. PubMed ID: 26751902
[TBL] [Abstract][Full Text] [Related]
30. Genomic Medicine Takes the Stage, Again!
Tempero M
J Natl Compr Canc Netw; 2018 Jul; 16(7):795. PubMed ID: 30006420
[No Abstract] [Full Text] [Related]
31. The era of precision oncogenomics.
Carpten JC; Mardis ER
Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29610397
[No Abstract] [Full Text] [Related]
32. Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways.
Doherty M; Metcalfe T; Guardino E; Peters E; Ramage L
Ann Oncol; 2016 Aug; 27(8):1644-6. PubMed ID: 27117532
[No Abstract] [Full Text] [Related]
33. Delivering precision oncology to patients with cancer.
Mateo J; Steuten L; Aftimos P; André F; Davies M; Garralda E; Geissler J; Husereau D; Martinez-Lopez I; Normanno N; Reis-Filho JS; Stefani S; Thomas DM; Westphalen CB; Voest E
Nat Med; 2022 Apr; 28(4):658-665. PubMed ID: 35440717
[TBL] [Abstract][Full Text] [Related]
34. Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade.
Alessandrini M; Chaudhry M; Dodgen TM; Pepper MS
OMICS; 2016 Oct; 20(10):593-603. PubMed ID: 27643672
[TBL] [Abstract][Full Text] [Related]
35. Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.
Nadauld LD; Ford JM; Pritchard D; Brown T
Health Aff (Millwood); 2018 May; 37(5):751-756. PubMed ID: 29733728
[TBL] [Abstract][Full Text] [Related]
36. CRISPR-Cas13a system: a novel approach to precision oncology.
Zhang J; You Y
Cancer Biol Med; 2020 Feb; 17(1):6-8. PubMed ID: 32296572
[No Abstract] [Full Text] [Related]
37. Perspective: The precision-oncology illusion.
Prasad V
Nature; 2016 Sep; 537(7619):S63. PubMed ID: 27602743
[No Abstract] [Full Text] [Related]
38. Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
Burstein HJ; Krilov L; Aragon-Ching JB; Baxter NN; Chiorean EG; Chow WA; De Groot JF; Devine SM; DuBois SG; El-Deiry WS; Epstein AS; Heymach J; Jones JA; Mayer DK; Miksad RA; Pennell NA; Sabel MS; Schilsky RL; Schuchter LM; Tung N; Winkfield KM; Wirth LJ; Dizon DS
J Clin Oncol; 2017 Apr; 35(12):1341-1367. PubMed ID: 28148207
[No Abstract] [Full Text] [Related]
39. Response to "personalized medicine, genomics, and pharmacogenomics".
Mayer DK
Clin J Oncol Nurs; 2014 Dec; 18(6):618. PubMed ID: 25427694
[No Abstract] [Full Text] [Related]
40. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]